Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576615 · ClinicalTrials.gov registry record
Propofol's Hypnotic and Memory Effects
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 102
- Enrollment target
NCT00576615: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00576615 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 102 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00576615 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to relate changes in the blood flow in your brain which are measured using magnetic resonance imaging (MRI) to temporary changes in your memory and level of sleepiness while receiving the drug propofol, which is commonly used to induce relaxation or sleepiness for minor surgical procedures. This study will help provide us information which will be useful in understanding which parts of the brain are influenced by these drugs to affect memory and sleepiness.
Interventions
- DRUG propofol
- DRUG Placebo solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2002-05 |
| Est. Completion | 2016-05 |
What the finished NCT00576615 record still lists
NCT00576615 is an observational study that tracks outcomes without assigning an intervention. The registered 102 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which propofol is the first listed.
NCT00576615 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00576615 about?
NCT00576615 is a clinical study titled "Propofol's Hypnotic and Memory Effects". The purpose of this study is to relate changes in the blood flow in your brain which are measured using magnetic resonance imaging (MRI) to temporary changes in your memory and level of sleepiness while receiving the drug propofol, which is commonly used to induce relaxation or sleepiness for minor ...
What is the current status of trial NCT00576615?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2002-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00576615?
The interventions under investigation include: propofol (DRUG), Placebo solution (DRUG).
Who is sponsoring clinical trial NCT00576615?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03704662 · 102 participants · NA
Preoperative Fractionated Radiation Therapy Versus Stereotactic Body Radiation Therapy for Resectable or Borderline Resectable, or Locally Advanced Type A Pancreatic Adenocarcinoma
- NCT04174742 · 102 participants
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
- NCT04275362 · 102 participants
Gait Analysis of a Lateral-Pivot Design Total Knee Replacement
- NCT04541082 · 102 participants · Phase 1
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia